Comparative Pharmacology
Head-to-head clinical analysis: CLONIDINE HYDROCHLORIDE AND CHLORTHALIDONE versus IOPIDINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLONIDINE HYDROCHLORIDE AND CHLORTHALIDONE versus IOPIDINE.
CLONIDINE HYDROCHLORIDE AND CHLORTHALIDONE vs IOPIDINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Clonidine is an alpha-2 adrenergic agonist that reduces sympathetic outflow from the CNS, decreasing peripheral resistance and heart rate. Chlorthalidone is a thiazide-like diuretic that inhibits sodium reabsorption in the distal convoluted tubule, reducing plasma volume.
Alpha-2 adrenergic agonist; reduces intraocular pressure by decreasing aqueous humor production and increasing uveoscleral outflow.
Oral: 1 tablet (0.1 mg clonidine/15 mg chlorthalidone) once daily, titrated up to maximum 4 tablets daily.
Adults: 1 drop of 0.5% or 1% ophthalmic solution in the affected eye(s) three times daily, beginning 48 hours prior to surgery and continuing on the day of surgery. Alternatively, for intraocular surgery, 1 drop of 1% solution is administered 1 hour before surgery and 1 drop immediately after surgery.
None Documented
None Documented
Clonidine: 12.7-16.9 hours (terminal), prolonged in renal impairment (up to 40 hours). Chlorthalidone: 40-60 hours (terminal), allowing once-daily dosing.
0.5-2 hours (terminal) for topical ophthalmic administration; clinical effect may persist longer due to local tissue binding.
Clonidine: ~40-60% excreted unchanged in urine, remainder as metabolites; renal elimination accounts for ~50-65% of total clearance. Chlorthalidone: ~50-65% excreted unchanged in urine, with ~30-50% undergoing renal tubular secretion; minimal biliary/fecal elimination (<10%).
Renal excretion (% unchanged drug not determined; metabolites excreted renally)
Category A/B
Category C
Alpha-2 Agonist
Alpha-2 Agonist